{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T10:43:39Z","timestamp":1762253019814,"version":"3.44.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"am","delay-in-days":368,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.bulcan.2019.04.004","type":"journal-article","created":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T20:32:24Z","timestamp":1559593944000},"page":"805-811","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Effets secondaires de la chimioth\u00e9rapie des cancers testiculaires et suivi de l\u2019apr\u00e8s cancer"],"prefix":"10.1016","volume":"106","author":[{"given":"Florence","family":"Joly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Djihane","family":"Ahmed-Lecheheb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Thiery-Vuillemin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emeline","family":"Orillard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elodie","family":"Coquan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bulcan.2019.04.004_bib0230","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.mcna.2017.10.003","article-title":"Testicular cancer: epidemiology, diagnosis, and management","volume":"102","author":"Smith","year":"2018","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.bulcan.2019.04.004_bib0235","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/02841860701367878","article-title":"Cancer survivorship research: state of knowledge, challenges and opportunities","volume":"46","author":"Aziz","year":"2007","journal-title":"Acta Oncol"},{"issue":"30","key":"10.1016\/j.bulcan.2019.04.004_bib0240","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.1200\/JCO.2012.43.4431","article-title":"Long-term and late effects of germ cell testicular cancer treatment and implications for follow-up","volume":"30","author":"Haugnes","year":"2012","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.bulcan.2019.04.004_bib0245","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.urolonc.2014.11.012","article-title":"Pulmonary and cardiovascular toxicity in long-term testicular cancer survivors","volume":"33","author":"Haugnes","year":"2015","journal-title":"Urol Oncol"},{"issue":"1","key":"10.1016\/j.bulcan.2019.04.004_bib0250","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1016\/S1166-7087(16)30706-0","article-title":"CCAFU french national guidelines 2016-2018\u00a0on testicular germ cell tumors","volume":"27","author":"Durand","year":"2016","journal-title":"Prog Urol"},{"issue":"1","key":"10.1016\/j.bulcan.2019.04.004_bib0255","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.2047-2927.2014.00250.x","article-title":"Testicular cancer and sperm DNA damage: short- and long-term effects of antineoplastic treatment","volume":"3","author":"Paoli","year":"2015","journal-title":"Andrology"},{"issue":"11","key":"10.1016\/j.bulcan.2019.04.004_bib0260","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1093\/humrep\/del167","article-title":"Effect of chemo- or radiotherapy on sperm parameters of testicular cancer patients","volume":"21","author":"Gandini","year":"2006","journal-title":"Hum Reprod"},{"issue":"4","key":"10.1016\/j.bulcan.2019.04.004_bib0265","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/annonc\/mds579","article-title":"Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer","volume":"24","author":"Beyer","year":"2013","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.bulcan.2019.04.004_bib0270","first-page":"2973","article-title":"Cognitive impairment in testicular cancer survivors 2\u00a0to 7\u00a0years after treatment","volume":"23","author":"Amidi","year":"2015","journal-title":"Support Care Cancer"},{"issue":"5","key":"10.1016\/j.bulcan.2019.04.004_bib0275","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1634\/theoncologist.2017-0457","article-title":"Long-term cognitive functioning in testicular germ-cell tumor survivors","volume":"23","author":"Chovanec","year":"2018","journal-title":"Oncologist"},{"issue":"3","key":"10.1016\/j.bulcan.2019.04.004_bib0280","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s11682-016-9552-3","article-title":"Changes in cognitive functions and cerebral grey matter and their associations with inflammatory markers, endocrine markers, and APOE genotypes in testicular cancer patients undergoing treatment","volume":"11","author":"Amidi","year":"2017","journal-title":"Brain Imaging Behav"},{"issue":"1","key":"10.1016\/j.bulcan.2019.04.004_bib0285","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/cncr.25298","article-title":"Cognitive impairment in men with testicular cancer prior to adjuvant therapy","volume":"117","author":"Wefel","year":"2011","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.bulcan.2019.04.004_bib0290","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s11764-016-0548-1","article-title":"Long-term health effects among testicular cancer survivors","volume":"10","author":"Hashibe","year":"2016","journal-title":"J Cancer Surviv"},{"issue":"15","key":"10.1016\/j.bulcan.2019.04.004_bib0295","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1200\/JCO.2017.77.0735","article-title":"Cumulative burden of morbidity among testicular cancer survivors after standard cisplatin-based chemotherapy: a multi-institutional study","volume":"36","author":"Kerns","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bulcan.2019.04.004_bib0300","doi-asserted-by":"crossref","first-page":"8671832","DOI":"10.1155\/2018\/8671832","article-title":"Toxicities associated with cisplatin-based chemotherapy and radiotherapy in long-term testicular cancer survivors","volume":"2018","author":"Fung","year":"2018","journal-title":"Adv Urol"},{"issue":"11","key":"10.1016\/j.bulcan.2019.04.004_bib0305","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1093\/annonc\/mdx360","article-title":"Long-term toxicity of cisplatin in germ-cell tumor survivors","volume":"28","author":"Chovanec","year":"2017","journal-title":"Ann Oncol"},{"issue":"12","key":"10.1016\/j.bulcan.2019.04.004_bib0310","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1038\/sj.bjc.6605095","article-title":"Evaluation of sub-acute changes in cardiac function after cisplatin-based combination chemotherapy for testicular cancer","volume":"100","author":"Altena","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bulcan.2019.04.004_bib0315","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1093\/annonc\/mdr408","article-title":"Longitudinal changes in cardiac function after cisplatin-based chemotherapy for testicular cancer","volume":"22","author":"Altena","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bulcan.2019.04.004_bib0320","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/jnci\/djq216","article-title":"Testicular cancer survivorship: research strategies and recommendations","volume":"102","author":"Travis","year":"2010","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.bulcan.2019.04.004_bib0325","first-page":"247","article-title":"Vascular damage in testicular cancer patients: a study on endothelial activation bybleomycin and cisplatin in vitro","volume":"23","author":"Nuver","year":"2010","journal-title":"Oncol Rep"},{"issue":"3","key":"10.1016\/j.bulcan.2019.04.004_bib0330","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1200\/JCO.2011.37.4025","article-title":"Impact of long-term serum platinum concentrations on neuro- and ototoxicity in Cisplatin-treated survivors of testicular cancer","volume":"30","author":"Sprauten","year":"2012","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.bulcan.2019.04.004_bib0335","doi-asserted-by":"crossref","first-page":"121","DOI":"10.12788\/jcso.0033","article-title":"Health behaviors among testicular cancer survivors","volume":"12","author":"Reilley","year":"2014","journal-title":"J Community Support Oncol"},{"issue":"1","key":"10.1016\/j.bulcan.2019.04.004_bib0340","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/bjc.2013.226","article-title":"Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors","volume":"109","author":"Willemse","year":"2013","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.bulcan.2019.04.004_bib0345","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1093\/annonc\/mds527","article-title":"Early development of the metabolic syndrome after chemotherapy for testicular cancer","volume":"24","author":"de Haas","year":"2013","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.bulcan.2019.04.004_bib0350","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1024\/1661-8157\/a001564","article-title":"Post treatment follow-up of patients with testicular cancer by primary care physicians","volume":"103","author":"Steiner","year":"2014","journal-title":"Praxis"},{"issue":"30","key":"10.1016\/j.bulcan.2019.04.004_bib0355","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1200\/JCO.2013.50.3409","article-title":"Solid tumors after chemotherapy or surgery for testicular nonseminoma: a population-based study","volume":"31","author":"Fung","year":"2013","journal-title":"J Clin Oncol"},{"issue":"14","key":"10.1016\/j.bulcan.2019.04.004_bib0360","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1093\/jnci\/92.14.1165","article-title":"Treatment-associated leukemia following testicular cancer","volume":"92","author":"Travis","year":"2000","journal-title":"J Natl Cancer Inst"},{"issue":"18","key":"10.1016\/j.bulcan.2019.04.004_bib0365","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1093\/jnci\/dji278","article-title":"Second cancers among 40,576\u00a0testicular cancer patients: focus on long-term survivors","volume":"97","author":"Travis","year":"2005","journal-title":"J Natl Cancer Inst"},{"issue":"24","key":"10.1016\/j.bulcan.2019.04.004_bib0370","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1200\/JCO.2017.77.4174","article-title":"Risk of Solid Cancer After treatment of Testicular Germ Cell Cancer in the Platinum Era","volume":"36","author":"Groot","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bulcan.2019.04.004_bib0375","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1093\/jnci\/djp413","article-title":"Observational study of prevalence of long-term Raynaud-like phenomena and neurological side effects in testicular cancer survivors","volume":"101","author":"Brydoy","year":"2009","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.bulcan.2019.04.004_bib0380","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ucl.2015.05.002","article-title":"Long-term Morbidity of Testicular Cancer Treatment","volume":"42","author":"Fung","year":"2015","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.bulcan.2019.04.004_bib0385","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/jnci\/djk111","article-title":"Noncancer causes of death in survivors of testicular cancer","volume":"99","author":"Fossa","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bulcan.2019.04.004_bib0390","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1200\/JCO.2008.18.5181","article-title":"Pulmonary function in long-term survivors of testicular cancer","volume":"27","author":"Haugnes","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bulcan.2019.04.004_bib0395","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.critrevonc.2017.11.015","article-title":"Long-term toxicity of the treatment for germ cell-cancer. \u00c0 review","volume":"121","author":"Maroto","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"issue":"13","key":"10.1016\/j.bulcan.2019.04.004_bib0400","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1200\/JCO.2015.64.8451","article-title":"Pulmonary Function in Patients With Germ Cell Cancer Treated With Bleomycin Etoposide, and Cisplatin","volume":"34","author":"Lauritsen","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bulcan.2019.04.004_bib0405","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/annonc\/mdf048","article-title":"Long-term renal function after treatment for malignant germ-cell tumours","volume":"13","author":"Fossa","year":"2002","journal-title":"Ann Oncol"},{"issue":"5.","key":"10.1016\/j.bulcan.2019.04.004_bib0410","article-title":"Chemotherapy- induced peripheral neurotoxicity and ototoxicity: new paradigms for translational genomics","volume":"106","author":"Travis","year":"2014","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.bulcan.2019.04.004_bib0415","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3109\/0284186X.2014.995775","article-title":"Chemotherapy-induced peripheral neuropathy in patients treated with taxanes and platinum derivatives","volume":"54","author":"Ewertz","year":"2015","journal-title":"Acta Oncol"},{"issue":"4","key":"10.1016\/j.bulcan.2019.04.004_bib0420","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jpsychores.2008.01.002","article-title":"Chronic cancer-related fatigue in long-term survivors of testicular cancer","volume":"64","author":"Orre","year":"2008","journal-title":"J Psychosom Res"},{"issue":"10","key":"10.1016\/j.bulcan.2019.04.004_bib0425","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1093\/annonc\/mdv328","article-title":"Chronic fatigue in 812\u00a0testicular cancer survivors during long-term follow-up: increasing prevalence and risk factors","volume":"26","author":"Sprauten","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bulcan.2019.04.004_bib0430","article-title":"Guidelines on Male Hypogonadism","author":"Doble","year":"2015","journal-title":"EAU guidelines"},{"key":"10.1016\/j.bulcan.2019.04.004_bib0435","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.genhosppsych.2015.09.001","article-title":"Anxiety and depression in long-term testicular germ cell tumor survivors","volume":"38","author":"Vehling","year":"2016","journal-title":"Gen Hosp Psychiatry"},{"issue":"7","key":"10.1016\/j.bulcan.2019.04.004_bib0440","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s12032-014-0043-3","article-title":"Sexual satisfaction, anxiety, depression and quality of life in testicular cancer survivors","volume":"31","author":"Alacacioglu","year":"2014","journal-title":"Med Oncol"},{"issue":"35","key":"10.1016\/j.bulcan.2019.04.004_bib0445","doi-asserted-by":"crossref","first-page":"5993","DOI":"10.1200\/JCO.2008.19.6931","article-title":"Health-related quality of life in long-term survivors of testicular cancer","volume":"27","author":"Rossen","year":"2009","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.bulcan.2019.04.004_bib0225","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.urolonc.2015.09.005","article-title":"Age-related variation and predictors of long-term quality of life in germ cell tumor survivors","volume":"34","author":"Hartung","year":"2016","journal-title":"Urol Oncol"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000745511930195X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000745511930195X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T19:31:07Z","timestamp":1757791867000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000745511930195X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S000745511930195X"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2019.04.004","relation":{},"ISSN":["0007-4551"],"issn-type":[{"type":"print","value":"0007-4551"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effets secondaires de la chimioth\u00e9rapie des cancers testiculaires et suivi de l\u2019apr\u00e8s cancer","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2019.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer.","name":"copyright","label":"Copyright"}]}}